Background. Although the level of erythrocyte complement receptor type 1 (E-CR1) expression in patients with malaria has been extensively studied, whether the level of expression of E-CR1 is associated with severe malaria remains controversial. The present study examined a possible association of polymorphisms in the CR1 gene with the severity of malaria, and it evaluated the influence of the associated polymorphism on expression of E-CR1.
cipally include opsonization, control of complement activation, and removal of immune complexes (ICs) [3] . CR1 plays a major role in IC clearance because of its high affinity for C3b and C4b [4] . Erythrocyte CR1 (E-CR1), through a process known as "immune adherence," binds the ICs (C1q, C4b, C3b, and C3bi) in the peripheral blood and transports them to the phagocytes in the liver and spleen, to remove them from the circulation [5] . The rate of clearance of ICs from the circulation is directly related to the number of CR1 molecules expressed on the erythrocytes [6] .
In humans, E-CR1 expression varies considerably-namely, as much as 20-fold (50 -1200 molecules/cell)-between individuals [1, 7] . It has been suggested that the quantitative expression of CR1 on erythrocytes is in part genetically determined by a single-nucleotide polymorphism (SNP) in intron 27 of CR1 (hereafter referred to as the "HindIII SNP" [rs11118133] in this article), which can be genotyped using the HindIII restriction enzyme [8 -10] . The HindIII SNP is composed of A and T, which correspond to high-expression (H) and low-expression (L) alleles, respectively. In several populations, such as those in Papua New Guinea [7] , Thailand [11] , and the United Kingdom [7] , and in white populations [12] , the H and L alleles of the HindIII SNP have been reported to denote the level of E-CR1 expression. However, some studies have revealed inconsistent results [12, 13] . In addition, a recent study revealed that the E-CR1 expression level is not associated with polymorphisms upstream of or in the 3' untranslated regions (UTRs) of the CR1 gene in populations from Papua New Guinea, Mali, and the United Kingdom [14] . Therefore, the functional cis element regulating CR1 expression is still in question.
E-CR1 has been considered to play an important role in "rosette formation," a phenomenon resulting from adhesion of Plasmodium falciparum erythrocyte membrane protein 1 (PFEMP-1) on the surface of infected RBCs to a variety of uninfected RBC membrane receptors, such as CR1 [3, [15] [16] [17] . This aggregation causes considerable obstruction of the cerebral microvasculature, thus contributing to the pathologic changes in cerebral malaria [18, 19] , severe malaria-associated anemia [20, 21] , or both [22, 23] . However, no significant association between rosetting and the severity of malaria has been observed in studies performed to date [24, 25] . This may be because there are other factors, such as the level of parasitemia [26] and the type of parasite isolates [27] , that influence the degree of rosetting. Therefore, there seems to be little agreement as to whether a high level of E-CR1 expression contributes to moresevere clinical symptoms of P. falciparum malarial infection through rosette formation. The aims of the present study are (1) to identify the CR1 polymorphism associated with either susceptibility to or protection against severe malaria in Thai patients with malaria and (2) to examine the influence of the polymorphisms detected on the E-CR1 expression level.
PATIENTS, MATERIALS, AND METHODS

Association Study
Patients. For all patients with malaria, malarial infection with P. falciparum was confirmed by a blood smear result positive for the asexual form of P. falciparum. Clinical manifestations of malaria were classified according to the definitions and associated criteria set forth by the World Health Organization. The patients were selected from groups with 3 different types of malaria (i.e., mild malaria, noncerebral severe malaria, and cerebral malaria). The mild malaria group consisted of 203 patients with mild symptoms who were characterized by fever without other causes of infection but by none of the manifestations of severe malaria described below. The noncerebral severe malaria group (hereafter referred to the "severe malaria group") comprised 165 patients with severe malaria, which was defined as malaria with evidence of vital organ dysfunction or with one of the following signs of severity: a high level of parasitemia (Ͼ100,000 parasites/ mL), hypoglycemia (plasma glucose level Ͻ22 nmol/L), severe anemia (a hematocrit of Ͻ20% or a hemoglobin level Ͻ7 g/dL), or a serum creatinine level Ͼ3 mg/dL. The cerebral malaria group consisted of 109 patients who experienced a coma from which they could not be roused and for whom noncerebral causes of coma could be excluded. All of the patients were 13 years of age, and the mean ages of the patients with mild malaria, severe malaria, and cerebral malaria were 25.3, 23.8, and 28.6 years, respectively. In the present study, the mild malaria group was used as a control group in association tests. All patients enrolled in the study were living in northwestern Thailand near the border between Thailand and Myanmar. All patients underwent treatment at the Hospital for Tropical Disease, Mahidol University (Bangkok, Thailand). The study was approved by the institutional review board of the Faculty of Tropical Medicine, Mahidol University, and the research ethics committee of the Faculty of Medicine, University of Tokyo (Tokyo, Japan). Written informed consent was obtained from all patients.
DNA extraction. Genomic DNA was extracted from peripheral blood leukocytes by use of a QIAamp blood kit (Qiagen), according to the manufacturer's recommendations.
Selection of SNPs and variation screening. The human CR1 gene spans Ͼ145 kb on chromosome 1 and is composed of 476 SNPs (National Center for Biotechnology Information SNP database [NCBI dbSNP] database; build 127). It is, therefore, absolutely rational to prioritize nonsynonymous SNPs in the CR1 coding region that can cause amino acid alteration and, consequently, influence CR1 protein conformation. By use of A1 in the appendix, which is available only in the print version of the Journal). For rs73689510, rs2274567, rs11118133 (HindIII SNP), rs3811381, and rs2296160, genotypes were determined by PCR and restriction fragment-length polymorphism identification (PCR-RFLP), with the use of restriction enzymes MvaI, RsaI, HindIII, MnlI and Alw44I for digestion, respectively. To avoid any missed genotyping, all RFLP experiments were performed together with 3 control (known-genotype) samples obtained from direct sequencing in the variation screening process. For other SNPs, genotypes were determined by PCR-direct sequencing performed using the BigDye Terminator Cycle Sequencing Ready Reaction Kit (version 3.1) in an ABI Prism 3100 (Applied Biosystems).
Statistical analyses. The allele and genotype frequencies were compared between the mild and severe malaria groups, as well as between the mild and cerebral malaria groups, by use of the 2 test and SNPalyze software (version 3.2 Pro; Dynacom). The ancestral allele for each SNP was determined based on the genome sequence of Pan troglodytes, which were obtained from the NCBI Map Viewer [28] . Statistical significance was denoted by P Ͻ .05. Haploview software (version 4.0) [29] was used to calculate the pairwise linkage disequilibrium (LD) coefficient (D' and r 2 ), to infer haplotype, to generate LD plots, and to test for haplotype association by the permutation test. The haplotype blocks subjected to the permutation test were defined manually as follows: block 1 consisted of SNPs in the CR1 promoter region; block 2, SNPs in the CR1 coding region; and block 3, SNPs in the 3' UTR. A permutation P value of Ͻ.05, obtained from 100,000 permutations performed for the aforementioned 3 haplotype blocks, was considered to denote statistically significance.
CR1 Expression Study
Subjects. Fresh blood samples were obtained from 200 healthy individuals living in Tak province, which is one of the areas of endemicity for serious malaria in the northwestern area of Thailand. Blood samples then were immediately preserved in EDTA at 4°C. Cells preserved in EDTA at 4°C can be used to assess the E-CR1 level accurately up to 2 weeks after the blood is drawn; thereafter, underestimation of the level can occur [30] . All individuals were 20 years of age, and the mean subject age was 37 years. All individuals presented in healthy condition. Fever was defined as an axillary temperature of Ͻ37.2°C. However, because asymptomatic malarial infection occasionally was observed in this area, all blood samples were confirmed to be negative for malarial infection by Giemsa staining and thick-film microscopic examination and by PCR evaluation for malarial rRNA. The samples were ethically approved by the institutional review board of the Faculty of Medicine, Chulalongkorn University (Bangok, Thailand).
DNA extraction and SNP genotyping. Genomic DNA was extracted from whole blood by use of a QIAamp DNA extraction kit (Qiagen) according to the manufacturer's recommendations. Promoter SNPs were brought into focus. For 200 healthy individuals, genotypes of rs7525160, rs7525170, and rs9429942 were determined by PCR-direct sequencing with the use of primer pairs described in table A1 in the appendix, which is available only in the print version of the Journal. In addition, PCR-RFLP was performed to genotype HindIII SNP (rs11118133). For the TT and TC genotypes of rs9429942, 12 samples each were selected for measurement of E-CR1. In each genotype group, onehalf of the samples had the HH genotype of the HindIII SNP, and the other half had the HL genotype.
Flow cytometric analysis. The density of CR1 on erythrocytes was measured according to a method described elsewhere [30] , with minor modification. In brief, whole blood preserved in EDTA was centrifuged at 400 g for 10 min at room temperature, to remove the buffy coat (i.e., the leukocyte-rich layer). Afterward, 50 L of leukocyte-depleted blood was used in preparation for measurement of E-CR1 by flow cytometry. During the cell preparation step, 50 L of leukocyte-depleted blood was initially washed 3 times in 1 mL of PBS-RPMI-ABS (i.e., PBS plus 4% RPMI 1640 plus 1% human AB serum). Cells were resuspended in 1 mL of PBS-RPMI-ABS, and 100 L of this suspension was placed into 2 new tubes for the next step. One tube was incubated with 40 L of 0.5 g/mL CR1 monoclonal antibody J3D3 (Beckman Coulter) in PBS-RPMI at 4°C for 1 h with occasional agitation. The other tube for isotypic control was incubated with mouse IgG1 (Beckman Coulter) at 4°C for 1 h with occasional agitation. Afterward, both tubes were washed 3 times in PBS-RPMI-ABS and were incubated with 10 g of Alexa Fluor 488 conjugated goat anti-mouse IgG1 (A21121; Invitrogen) at 4°C, with no exposure to light for 1 h and with occasional agitation. Thereafter, all samples were washed 3 times in PBS-RPMI-ABS and were ready for analysis on the flow cytometer (Epics XL; Beckman Coulter). According to size, the gating strategy was used to define the absolute erythrocyte subset and to gate out platelets and cell debris. The mean fluorescence intensity (MFI) of each sample and isotypic control was measured 3 times in succession. The number of E-CR1 copies for each individual was calculated as the average MFI of each sample minus the average MFI of the isotypic control. All samples were studied on the same day, and this expression study was completed within 2 weeks after blood samples were obtained.
Statistical analysis. The differences in the number of E-CR1 copies between 2 different genotypes were assessed by the Mann-Whitney U test. A 2-tailed P value of Ͻ.05 denoted statistical significance in the analysis of rs9429942, whereas a 1-tailed P value of Ͻ.05 denoted statistical significance in the HindIII SNP analysis, because the alleles with higher (H) and lower (L) expression had been reported.
RESULTS
Association Study
Individual SNPs. In the variation screening, 17 SNPs (4 SNPs in the CR1 putative promoter region, 7 nonsynonymous SNPs in exons, the HindIII SNP in intron 27, and 5 SNPs in the 3' UTR) were identified as being polymorphic in 32 subjects in the study population (table 1) , and, therefore, the possible association of these SNPs with the severity of malaria was further investigated. Two promoter SNPs, rs7525170 and rs9429942, showed significant differences in genotype and allele frequencies between the mild malaria group and the cerebral malaria group (tables 2 and 3). The association of the T allele of rs9429942 (rs9429942-T) with protection against cerebral malaria was very strong (P ϭ .0009; allelic odds ratio [OR], 0.25; 95% confidence interval [CI], 0.11-0.56) (table 3) and was found to still be significant after Bonferroni correction (P c ϭ .0009 ϫ 17 ϫ 2 ϭ 0.0306). In the present study, the derived allele was the focus of the association test, regardless of the allele frequency. Although a significant association between the HindIII SNP and malaria severity has been reported [11, 31] , no association was detected in the present study (P ϭ .9918, for the mild malaria group vs. the cerebral anemia group; P ϭ .1915, for the mild malaria group vs. the severe malaria group) (table 3) . No significant difference was observed for 7 nonsynonymous SNPs and 5 SNPs in the 3' UTR in Thai patients with malaria.
LD and haplotype analysis. A comparison of the LD block structure revealed no remarkable difference between the mild malaria and cerebral malaria groups (figure 1). In the CR1 pro- moter region, rs9429942 was in strong LD with rs7525170 (D' ϭ 0.889; r 2 ϭ 0.73) but not with the other SNPs. Because of the strong LD, an apparent association was therefore thought to be observed for rs7525170 (P ϭ .0129, in table 3). Haplotype frequencies in 3 manually defined haplotype blocks (i.e., the promoter, coding, and 3' UTR regions) were further compared between the malaria groups (table 4). In the promoter region, 4 major haplotypes were observed (table 4) . Among these, haplotype GGCG showed a significant P value in the permutation test (P ϭ .0112). However, this finding seems to have resulted from the presence of the C allele of rs9429942. In the coding and 3' UTR regions, no haplotype showed a significant P value.
CR1 Expression Study
Because rs9429942 is located in the CR1 putative promoter region, and because the T allele showed strong association with protection against cerebral malaria, the effect of rs9429942-T on E-CR1 expression was examined in healthy Thai individuals. The results showed that the level of CR1 expression on the erythrocytes of individuals with the TT genotype of rs9429942 (rs9429942-TT) was significantly higher than that of the individuals with the TC genotype of rs9429942 (rs9429942-TC) (2-tailed P value, .0282) (figures 2A and 2C). It should be noted here that the number of each HindIII SNP (i.e., rs11118133) genotype was meticulously adjusted to be equal between 12 individuals with the TT genotype and 12 individuals with the TC genotype, to avoid the effect of HindIII SNP on E-CR1 expression. Namely, 6 individuals with rs9429942-TT and HindIII SNP genotype HH, 6 individuals with rs9429942-TC and HindIII SNP genotype HH, 6 individuals with rs9429942-TT and HindIII SNP genotype HL, and 6 individuals with rs9429942-TC and HindIII SNP genotype HL were subjected to the expression analysis. When the subjects were classified according to the HindIII SNP genotype (HH or HL), the difference was not statistically significant (1-tailed P value, .0716) (figure 2B).
DISCUSSION
The present study revealed that rs9429942-T in the CR1 putative promoter region was strongly associated with protection against cerebral malaria (P ϭ .0009; Bonferroni-adjusted P c ϭ .0306). Furthermore, the expression analysis showed the E-CR1 copy number to be significantly higher in individuals with rs9429942-TT than in individuals with rs9429942-TC (P ϭ .0282). Therefore, rs9429942-T was also associated with a high level of expression of E-CR1. These observations suggest that a higher level of E-CR1 expression contributes to protection against cerebral malaria, although the expression of E-CR1 was evaluated in healthy individuals rather than in patients with malaria. The rate of clearance of ICs from the circulation was reported to be positively correlated with the number of E-CR1 copies [6, [32] [33] [34] . This evidence, together with the current findings, prompts the following hypothesis regarding the pathogenesis of cerebral ma- laria. The lower expression of E-CR1 determined by the CR1 promoter polymorphism results in a higher deposition of ICs. This causes tissue damage or cell aggregation, which leads to severe clinical characteristics, including cerebral malaria. On the other hand, the higher expression of E-CR1 can help to prevent the development of such severe symptoms by means of efficient clearance of ICs. However, there are contradictory reports that have noted that a higher number of copies of E-CR1 results in a higher degree of rosette formation [3, [15] [16] [17] and that high rosetting is associated with the severe clinical syndrome of malaria infection [18, 19, 21, 22] . Thus, the present findings should be replicated in independent studies, and our hypothesis remains open to debate.
To examine the extent of LD associated with rs9429942 in the Asian population, rs9429942 and rs7525170 were genotyped for 45 Han Chinese (CHB) who were the HapMap panel subjects [35] . The genotype data are available on request. The results showed that rs9429942 was in absolute LD (r 2 ϭ 1) with 10 neighboring SNPs, including rs7525170 in CHB. Because these SNPs span 11.4 kb (from rs2182911 to rs4274065), the length of strong LD associated with rs9429942 seems to be small. Therefore, within the small region, there would be a polymorphism primarily associated with protection against cerebral malaria and with E-CR1 expression, although whether a similar pattern of LD was observed in the present Thai subjects should be clarified in future studies. of erythrocyte CR1 (E-CR1) copies (mean fluorescence intensity) for a single individual, and points to the right (closed squares) denote the median value for each genotype. It should be noted that the 2-tailed P value and 1-tailed P value, as determined by the Mann-Whitney U test, were calculated for rs9429942 and the HindIII SNP, respectively. C, Plotted histograms show representative data for rs9429942. MFI, mean fluorescence intensity.
Because rs9429942 is located in the putative promoter region of the CR1 gene, potential transcription-binding sites were searched using Tfsitescan, which is maintained by the Institute for Transcriptional Informatics (Pittsburgh, Pennsylvania). Interestingly, the site of rs9429942 was found to represent a perfectly matched binding sequence for the transcription factor Brn-2 (OMIM accession number MIM *600494), a member in the class III POU domain family (ATGCATW [the site of rs9429942 is underlined]). POU domain factors are transcriptional regulators. The change in the nucleotide sequence at the transcription factor binding site has the potential to affect the binding affinity and, subsequently, influence the level of gene expression. Several members of the POU domain family have been implicated in the control of the development and functions of the neuroendocrine system [36] . To date, study of the POU domain family has mainly focused on the neuroendocrine system rather than immunologic or hematologic systems. Therefore, it remains to be studied whether this transcription factor can bind the CR1 promoter and regulate the E-CR1 expression level.
It has been reported that the level of E-CR1 expression is regulated by the HindIII SNP (intron 27) [7, 11, 12] and the African allelic forms (nonsynonymous SNPs) in exon 29 (short consensus repeats 24 and 25 of E-CR1 protein) [12] . In the present study, the E-CR1 expression level was found to be significantly associated with rs9429942, but not with HindIII SNP and an African allelic form (rs6691117). In the population studied, rs6691117 was in absolute LD (r 2 ϭ 1) with HindIII SNP (data not shown). Because the influence of rs9429942 on the level of E-CR1 expression has not yet been examined, the apparent or indirect association between the HindIII SNP and the E-CR1 expression level in previous studies may have been caused by the strong LD of HindIII SNP with rs9429942. However, the possibility that, independent of rs9429942, HindIII SNP is associated with the E-CR1 expression level should not be excluded, because we found a tendency for individuals with the HH genotype to express more E-CR1 than individuals with the HL genotype (1-tailed P value, .0716) ( figure 2B ). The present result, indicating no association between the HindIII SNP and E-CR1 expression levels, may be a result of the small sample size, and the level of E-CR1 expression might also be influenced by both polymorphisms: rs9429942 and HindIII SNP. This possibility should thus be further investigated.
